Literature DB >> 16614794

Successful use of cyclosporin A in severe Schönlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine.

Jae Il Shin1, Jee Min Park, Jae Seung Lee, Ji Hong Kim, Pyung Kil Kim, Hyeon Joo Jeong.   

Abstract

Schönlein-Henoch nephritis (SHN) usually presents with micro-haematuria or mild proteinuria but can be associated with heavy proteinuria and nephrotic or acute nephritic syndrome. Although the treatment of SHN is still under debate, it has been suggested that cyclosporin A (CsA) may be beneficial in children with severe SHN, as reported by Ronkainen et al. (Pediatr Nephrol 18:1138-1142, 2003) and Someya et al. (Pediatr Int 46:111-113, 2004). However, histological effects of CsA on severe SHN had not been evaluated in their evaluations. We report the successful use of CsA in a male patient with severe SHN with nephrotic-range proteinuria, who failed to respond to methylprednisolone pulse and azathioprine therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614794     DOI: 10.1007/s10067-005-0066-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Cyclosporine A for heavy proteinuria in a child with Henoch-Schönlein purpura nephritis.

Authors:  Tomonosuke Someya; Kazunari Kaneko; Shuichiro Fujinaga; Risako Ohtaki; Mayako Hira; Yuichiro Yamashiro
Journal:  Pediatr Int       Date:  2004-02       Impact factor: 1.524

2.  Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids.

Authors:  Surjit Singh; Lata Kumar; Kusum Joshi; Ranjana W Minz; Usha Datta
Journal:  Rheumatol Int       Date:  2002-07-05       Impact factor: 2.631

3.  Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy.

Authors:  S Ambalavanan; J P Fauvel; R K Sibley; B D Myers
Journal:  J Am Soc Nephrol       Date:  1996-02       Impact factor: 10.121

4.  Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.

Authors:  R Zietse; G J Wenting; P Kramer; M A Schalekamp; W Weimar
Journal:  Clin Sci (Lond)       Date:  1992-06       Impact factor: 6.124

5.  Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis.

Authors:  Jaana Ronkainen; Helena Autio-Harmainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2003-08-19       Impact factor: 3.714

6.  Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis.

Authors:  P Niaudet; R Habib
Journal:  Pediatr Nephrol       Date:  1998-04       Impact factor: 3.714

  6 in total
  7 in total

Review 1.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

2.  Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity.

Authors:  Takeshi Ninchoji; Hiroshi Kaito; Kandai Nozu; Yuya Hashimura; Kyoko Kanda; Ichiro Kamioka; Yuko Shima; Kiyoshi Hamahira; Koichi Nakanishi; Ryojiro Tanaka; Norishige Yoshikawa; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

3.  Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.

Authors:  Outi Jauhola; Jaana Ronkainen; Helena Autio-Harmainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2011-05-28       Impact factor: 3.714

Review 4.  Systemic vasculitis in childhood.

Authors:  Abraham Gedalia; Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

5.  Could intravenous cyclosporin A be an effective therapeutic strategy in pulmonary hemorrhage associated with Henoch-Schönlein purpura? Comment on: Pulmonary hemorrhage associated with Henoch-Schönlein purpura in a child [Clin Rheumatol 27(6):803-805].

Authors:  Jae Il Shin; Jae Seung Lee
Journal:  Clin Rheumatol       Date:  2008-08-21       Impact factor: 2.980

6.  Successful outcome of a corticodependent henoch-schönlein purpura adult with rituximab.

Authors:  Taylor Pindi Sala; Jean-Marie Michot; Renaud Snanoudj; Marion Dollat; Emmanuel Estève; Bernadette Marie; Yacine Taoufik; Jean-François Delfraissy; Thierry Lazure; Olivier Lambotte
Journal:  Case Rep Med       Date:  2014-04-01

7.  Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma.

Authors:  Naoki Akizue; Eiichiro Suzuki; Masayuki Yokoyama; Masanori Inoue; Toru Wakamatsu; Tomoko Saito; Yuko Kusakabe; Sadahisa Ogasawara; Yoshihiko Ooka; Akinobu Tawada; Yugo Maru; Hiroyuki Matsue; Tetsuhiro Chiba
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.